NCT03215875View on ClinicalTrials.gov

A Food Effect Study of 60mg ER Torsemide

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 17, 2017

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Food-drug Interaction
Interventions
DRUG

Fed- 60mg ER Torsemide

60mg ER Torsemide will be given after high fat, high-calorie meal

DRUG

Fasting- 60mg ER Torsemide

60mg ER Torsemide will be given after overnight fasting

Trial Locations (1)

560003

I.E.C. Consultants, Bangalore

All Listed Sponsors
lead

Sarfez Pharmaceuticals, Inc.

INDUSTRY

NCT03215875 - A Food Effect Study of 60mg ER Torsemide | Biotech Hunter | Biotech Hunter